← brief for 2026-08-18 · Slowing decline
Combination Pharmacotherapy in Type 2 Diabetes and Chronic Kidney Disease: Translating Evidence into Clinical Practice.
Key takeaways
A review of drugs for diabetes and kidney disease. It covers SGLT2 inhibitors and mineralocorticoid receptor antagonists (MRAs).
Who did this work
Lovshin JA
Source
Article · PubMed, the drug frontier · 2026 Aug 18
https://pubmed.ncbi.nlm.nih.gov/42611042/